LSD shows promise for reducing anxiety in drugmaker’s midstage study

The results from drugmaker Mindmed tested several doses of LSD in patients with moderate-to-severe generalized anxiety disorder, with the benefits lasting as long as three months. The company plans to conduct follow-up studies to confirm the results and then apply for Food and Drug Administration ap...

Redirecting to full article...